Advances in Human Papillomavirus

Human papillomavirus infection is an infection by human papillomavirus (HPV), a DNA virus from the papillomavirus family, of which over 150 types are known. Most HPV infections cause no symptoms and resolve spontaneously. More than 40 types are transmitted through sexual contact and infect the anus and genitals. In some, they persist and result in warts or precancerous lesions. The precancerous lesions increase the risk of cancer of the cervix, vulva, vagina, penis, anus, mouth, or throat. Nearly all cervical cancer is due to HPV with two types, HPV16 and HPV18, accounting for 70% of cases. HPV is the most common sexually transmitted infection globally. Most people are infected at some point in their lives. Risk factors for persistent HPV infections include early age of first sexual intercourse, multiple partners, smoking, and poor immune function. Occasionally, it can spread from a mother to her baby during pregnancy.HPV vaccines can prevent the most common types of infection. 


In the present book, fifteen typical literatures about human papillomavirus published on international authoritative journals were selected to introduce the worldwide newest progress, which contains reviews or original researches on medical science, virus disease, virology, epidemiology, ect. We hope this book can demonstrate advances in human papillomavirus as well as give references to the researchers, students and other related people.

Components of the Book:
  • Chapter1
    High-Risk Human Papillomavirus Infection Is Associated with Premature Rupture of Membranes
  • Chapter 2
    Human Papillomavirus Detection in Women with and without Human Immunodeficiency Virus Infection in Colombia
  • Chapter 3
    Human Papillomavirus Genotypes in Human Immunodeficiency Virus-Positive Patients with Anal Pathology in Madrid, Spain
  • Chapter 4
    Human Papillomavirus Prevalence in South African Women and Men According to Age and Human Immunodeficiency Virus Status
  • Chapter 5
    Prevalence of Human Papillomavirus Infection in the Oropharynx and Urine among Sexually Active Men: A Comparative Study of Infection by Papillomavirus and Other Organisms, Including Neisseria Gonorrhoeae, Chlamydia Trachomatis, Mycoplasma Spp., and Ureaplasma Spp
  • Chapter 6
    Cost-Effectiveness Analysis of Human Papillomavirus Vaccination in South Africa Accounting for Human Immunodeficiency Virus Prevalence
  • Chapter 7
    The Diversity of Human Papillomavirus Infection among Human Immunodeficiency Virus-Infected Women in Yunnan, China
  • Chapter 8
    The Probability of Involvement of Human Papillomavirus in the Carcinogenesis of Bladder Small Cell Carcinoma, Prostatic Ductal Adenocarcinoma, and Penile Squamous Cell Carcinoma: A Case Report
  • Chapter 9
    Multiple Human Papillomavirus Infections Are Highly Prevalent in the Anal Canal of Human Immunodeficiency Virus-Positive Men Who Have Sex with Men
  • Chapter 10
    Identification of Novel Epitopes from Human Papillomavirus Type 18 E7 That Can Sensitize PBMCs of Multiple HLA Class I against Human Cervical Cancer
  • Chapter 11
    Increased Alpha-9 Human Papillomavirus Species Viral Load in Human Immunodeficiency Virus Positive Women
  • Chapter 12
    Human Papillomavirus Genotypes in Cervical Cancer and Vaccination Challenges in Zimbabwe
  • Chapter 13
    Invasive Cervical Cancers from Women Living in the United States or Botswana: Differences in Human Papillomavirus Type Distribution
  • Chapter 14
    Observations on the Expression of Human Papillomavirus Major Capsid Protein in HeLa Cells
  • Chapter 15
    Co‑Infection of Epstein‑Barr Virus and Human Papillomavirus in Human Tumorigenesis
Readership: Students, academics, teachers and other people attending or interested in Human Papillomavirus.
Min-Jeong Oh, Department of Obstetrics and Gynecology, College of Medicine, Korea University, Seoul, Korea.

Milena Camargo, Fundación Instituto de Inmunología de Colombia, Cra. 50 # 26-20, Bogotá, Colombia.

Ernesto Moro-Rodríguez, Department of Histology and Anatomical Pathology, Rey Juan Carlos University, School of Medicine, Madrid, Spain.

Kazuyoshi Shigehara, Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, 13-1, Takaramachi, Kanazawa, Ishikawa 920-8641, Japan.

Darron R. Brown, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.

Alejandro García-Carrancá, Unidad de Investigación Biomédica en Cáncer, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México and Instituto Nacional de Cancerología, SSA, México D.F., Mexico.

and more...
Copyright © 2006-2024 Scientific Research Publishing Inc. All Rights Reserved.
Top